Prime Medicine PRME Q1 2025 earnings
Reported May 8, 2025 · Before market open
Revenue$1.5MMiss by $879.3K
EPS-$0.40Miss by $0.08
Revenue estimate$2.3M
EPS estimate-$0.32
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$2.3M
EPS estimate-$0.24
Financials
Q1 2025Valuation & ratios
Segments
By segment
Versus estimates
Revenue
Diluted EPS
Ask the moment Prime Medicine reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Prime Medicine report Q1 2025 earnings?
- Prime Medicine (PRME) reported Q1 2025 earnings on May 8, 2025 before market open.
- What were Prime Medicine's Q1 2025 revenue and EPS?
- Prime Medicine reported revenue of $1.5M and eps of $-0.40 for Q1 2025.
- Did Prime Medicine beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $2.3M by $879.3K. EPS missed the consensus estimate of $-0.32 by $0.08.
- How did Prime Medicine's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 146.0% from $591.0K a year earlier and eps grew 9.1% from $-0.44.
- Where can I find Prime Medicine's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001628280-25-023486) directly on SEC EDGAR. The filing index links above go to sec.gov.